Startups
ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.
Summary
37
Industry
Total funding Amount
$190M
Fundraising History
-
Jun 01 '22 Unknown$100M
Investors
-
EurazeoUnknown
-
Earlybird Venture CapitalUnknown
-
Andera PartnersUnknown
-
GimvUnknown